The market for Hormones in Dosage Except Contraceptives and Antibiotics in Tunisia stood at $20.737 million in 2023. Over the past decade, the market has experienced fluctuations, with significant drops in 2015 and 2022. The last two years saw a decline, with a year-on-year decrease of 10.19% in 2022 and 1.2% in 2023. Over the last five years, the compound annual growth rate has been negative at -1.22%, indicating a general downtrend.

Future trends to watch for:

Potential recovery influenced by increased healthcare expenditure.
Opportunities for market growth with advancements in hormonal therapies.
Effects of regulatory changes and economic conditions on market dynamics.
Emerging competition from generic medication and innovative drug delivery systems.